BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38419526)

  • 1. Engineering an Escherichia coli based in vivo mRNA manufacturing platform.
    Curry E; Muir G; Qu J; Kis Z; Hulley M; Brown A
    Biotechnol Bioeng; 2024 Jun; 121(6):1912-1926. PubMed ID: 38419526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic engineering of Escherichia coli for de novo production of 3-phenylpropanol via retrobiosynthesis approach.
    Liu Z; Zhang X; Lei D; Qiao B; Zhao GR
    Microb Cell Fact; 2021 Jun; 20(1):121. PubMed ID: 34176467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic pathway for the production of 2-hydroxyisovaleric acid in Escherichia coli.
    Cheong S; Clomburg JM; Gonzalez R
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):579-588. PubMed ID: 29330665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of Escherichia Coli Cell Factories for Production of Organic Acids and Alcohols.
    Liu P; Zhu X; Tan Z; Zhang X; Ma Y
    Adv Biochem Eng Biotechnol; 2016; 155():107-40. PubMed ID: 25577396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-assisted metabolic engineering of Escherichia coli for long chain alkane and alcohol production.
    Fatma Z; Hartman H; Poolman MG; Fell DA; Srivastava S; Shakeel T; Yazdani SS
    Metab Eng; 2018 Mar; 46():1-12. PubMed ID: 29408291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Engineering of Escherichia coli for Natural Product Biosynthesis.
    Yang D; Park SY; Park YS; Eun H; Lee SY
    Trends Biotechnol; 2020 Jul; 38(7):745-765. PubMed ID: 31924345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free Synthetic Biology for Pathway Prototyping.
    Karim AS; Jewett MC
    Methods Enzymol; 2018; 608():31-57. PubMed ID: 30173768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
    Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
    Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome engineering of Escherichia coli for constitutive production of salvianic acid A.
    Zhou L; Ding Q; Jiang GZ; Liu ZN; Wang HY; Zhao GR
    Microb Cell Fact; 2017 May; 16(1):84. PubMed ID: 28511681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Scale Metabolic Modeling of Escherichia coli and Its Chassis Design for Synthetic Biology Applications.
    Mienda BS; Dräger A
    Methods Mol Biol; 2021; 2189():217-229. PubMed ID: 33180304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creating Polyploid Escherichia Coli and Its Application in Efficient L-Threonine Production.
    Wang S; Chen X; Jin X; Gu F; Jiang W; Qi Q; Liang Q
    Adv Sci (Weinh); 2023 Nov; 10(31):e2302417. PubMed ID: 37749873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems metabolic engineering of Escherichia coli for the heterologous production of high value molecules-a veteran at new shores.
    Becker J; Wittmann C
    Curr Opin Biotechnol; 2016 Dec; 42():178-188. PubMed ID: 27513555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysate of engineered Escherichia coli supports high-level conversion of glucose to 2,3-butanediol.
    Kay JE; Jewett MC
    Metab Eng; 2015 Nov; 32():133-142. PubMed ID: 26428449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic repetitive extragenic palindromic (REP) sequence as an efficient mRNA stabilizer for protein production and metabolic engineering in prokaryotic cells.
    Deng C; Lv X; Li J; Liu Y; Du G; Amaro RL; Liu L
    Biotechnol Bioeng; 2019 Jan; 116(1):5-18. PubMed ID: 30229865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR interference-guided multiplex repression of endogenous competing pathway genes for redirecting metabolic flux in Escherichia coli.
    Kim SK; Seong W; Han GH; Lee DH; Lee SG
    Microb Cell Fact; 2017 Nov; 16(1):188. PubMed ID: 29100516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifications of the 5' region of the CASPON
    Köppl C; Buchinger W; Striedner G; Cserjan-Puschmann M
    Microb Cell Fact; 2024 Mar; 23(1):86. PubMed ID: 38509572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo metabolic engineering and the promise of synthetic DNA.
    Klein-Marcuschamer D; Yadav VG; Ghaderi A; Stephanopoulos GN
    Adv Biochem Eng Biotechnol; 2010; 120():101-31. PubMed ID: 20186529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic engineering of Escherichia coli for de novo biosynthesis of vitamin B
    Fang H; Li D; Kang J; Jiang P; Sun J; Zhang D
    Nat Commun; 2018 Nov; 9(1):4917. PubMed ID: 30464241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering the pathway in Escherichia coli for the synthesis of medium-chain-length polyhydroxyalkanoates consisting of both even- and odd-chain monomers.
    Zhuang Q; Qi Q
    Microb Cell Fact; 2019 Aug; 18(1):135. PubMed ID: 31409350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole synthetic pathway engineering of recombinant protein production.
    Brown AJ; Gibson SJ; Hatton D; Arnall CL; James DC
    Biotechnol Bioeng; 2019 Feb; 116(2):375-387. PubMed ID: 30345502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.